Although robust expression of transgenes was confirmed via in vivo fluorescence imaging and bioluminescence imaging in the skin (Figure 6 A, B), skin tumors did not develop in double-transgenic (2PLEASE; R26-Cre-ERT2) mice following topical application of tamoxifen. The gene discussed is MAPK3; the disease is skin neoplasm.